Sree Rayalaseema Hi-Strength Hypo Proposes Rs 425 Crore RPT and Rs 3 Dividend

Turnover rose to Rs 666.96 Cr in FY 2025-26 from Rs 637.82 Cr, while Profit After Tax held steady at Rs 92.65 Cr.

Reader Takeaway: Stable turnover growth faces flat profit margins; focus shifts to large-scale related-party transactions with group entities.

What just happened

Sree Rayalaseema Hi-Strength Hypo Limited has announced its upcoming Annual General Meeting (AGM) scheduled for September 26, 2026. The board has recommended a final dividend of Rs 3 per equity share (face value Rs 10). A primary agenda item is the shareholder approval for material related-party transactions (RPTs) with TGV SRAAC Limited, projected at Rs 425 crore for FY 2026-27.

Why this matters

The proposed RPT value marks a significant jump from the Rs 104.46 crore recorded in FY 2025-26. This escalation in business dealings with a group entity requires close oversight regarding arm's-length pricing and business concentration risk. Simultaneously, the company is bolstering its governance by appointing Sri Kasturi Phaneendra Rao as an Independent Director for a five-year term.

Operational Performance

Financial results show a mixed bag: net sales for Calcium Hypo Chloride and Sodium Methoxide declined by 10.03% and 38.67% respectively. However, the company saw strong growth in Stable Bleaching Powder (3.52%) and Sodium Hydride (79.49%). Management continues to prioritize energy conservation, specifically through technology upgrades in sulphuric acid plants to improve yield and resource efficiency.

Risks to watch

Shareholders should track the high volume of business with TGV SRAAC Limited. Any governance or operational shift within this group entity could directly impact the company's revenue streams. Additionally, the flat year-on-year profit performance indicates that rising turnover has not yet translated into higher bottom-line growth, highlighting the need to watch margin compression in key product segments.